Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Pierre Falson

Pierre Falson

Principal Scientist IBCP France

Arvi Rauk

Arvi Rauk

Professor University of Calgary Canada

Shoujun Xu

Shoujun Xu

Professor University of Houston USA

Kal Ramnarayan

Kal Ramnarayan

President & Chief Scientific Officer Sapient Discovery, LLC USA

Alessandra Nurisso

Alessandra Nurisso

Associate Professor University of Geneva Switzerland

Yanli Wang

Yanli Wang

Principal Scientist National Institutes of Health USA

Jetze J. Tepe

Jetze J. Tepe

Professor Michigan State University USA

Tatsuya Takagi

Tatsuya Takagi

Professor Osaka University Japan

MedChem and TDD 2017, USA

About MedChem & TDD 2017

Conference Series Ltd welcome professional chemists, researchers, professors, scientific communities, delegates, students, business professionals and executives from all over the world to attend the “18th International Conference on Medicinal Chemistry and Targeted Drug Delivery”, from December  6-8, 2017 at Dallas USA.

Medicinal chemistry explores different ways how chemists are modifying molecules structure so as to design innocuous and effective drugs. It is one of the most rapidly developing areas within chemistry, both globally and locally.

The different spectroscopic techniques for drug design, synthesis and characterization of novel therapeutic agents including small molecules, peptide drugs and natural products will be discussed. Applications in novel methods of drug delivery systems and formulations for better bioavailability of bioactive compounds are also welcomed.

Conference Series Ltd organises 800+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 400+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

WHO SHOULD ATTEND?

Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from Pharmaceutical, Bio-pharmaceutical and Research Institutes working in,

Chemistry
Traditional Medicine
Pharmaceutical Sciences
Drug Delivery
Drug Designing
Drug Testing
Drug Discovery
Chromatographic Techniques
Pharmacology
Cancer Studies
Neurodegenerative Diseases
Personalised Medicines
Virology
Chemical Biology
Biomedical Sciences
Biochemistry
Organic Chemistry
Translational Sciences/Medicines

The scientific program includes Keynote & Plenary Talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists.

For abstract submission please click http://medicinalchemistry.pharmaceuticalconferences.com/abstract-submission.php

For registration click http://medicinalchemistry.pharmaceuticalconferences.com/registration.php

You can also mail us your abstract to address [email protected][email protected]

                                                                   
 

Sessions / TRACKS

Track 1 Medicinal Chemistry And Drug Discovery

Track 2 Fusion of Traditional And Biomedicine

Track 3   Plant Genomics

Track 4   Pharmaceuticals Vs Nutraceuticals

Track 5 Frontiers In Chemistry

Track 6 Computer Aided Drug Designing

Track 7 Targeted Drug Delivery System-TDDS (Smart Drug Delivery)

Track 8 Drug Chemistry

Track 9 Hyphenated Chromatographic Techniques

Track 10 Cancer Studies: Drug Delivery Chemistry

 

Track 11 Neuro Degenerative Disease

 

Track 12 Vaccines And Autism

Track 12 Emerging Infectious Diseases

Track 13 Antibiotics

Track 14 Personalised Medicines And Drugs

Track 15 Medchem-Antimicrobial And Infectious Agents

Track 16 Chem Virology (zika virus)

Track 17 New Trends In Pharmacology And Drug Development

Track 18 Novel Drug Discovery And Drug Delivery

 

 

Track 19 Chemical Biology

 

                                

Track 20 American Pharm

Track 21 Bio America

Track 22 Novel Research: Hit To Lead

 

 

 

 

 

 

                                  

 

 

Market analysis

chemistry

 

Importance & Scope:

Significance of recent trends reviews the state of the art and aims to determine the significance of technology and market trends in medicinal chemistry for advancing productivity in drug discovery. One in particular, fragment-based drug design, stands out as promising major improvements in research productivity. After analysis it proves that medicinal chemistry-related approaches and methodologies that drug discovery organizations employ in an effort to increase productivity in early drug discovery. Its key topics considered include structure-based drug design, fragment-based drug design, natural products-based drug design, diversity-oriented synthesis, and chemogenomics. Various ways of computer-aided drug design are also considered, as the complexity and limitations of drug discovery programs that are based on biochemical screens of large compound collections have been major factors in stimulating the growth of this modality.
 

Why Dallas, Texas?

Texas pharmaceutical giant maintained a robust lead over drug makers in our annual ranking of the largest Bio-Pharma companies in the United States of America.

However, the pharmaceutical market is still dominated by a few very large companies that control the import/distribution, retail and manufacturing sectors. While these companies have played an important role in the pharmaceutical sector’s development in Georgia, their market dominance leads to high mark-up for medicines which explain the high expenditures on pharmaceuticals. The mark-up for medicines in Georgia is far above the average mark-up for medicines than in European countries.
 

Conference Highlights:

Frontiers in Chemistry
Pharmaceutical Chemistry
Novel Drug Discovery & Drug Delivery
Computer Aided Drug Designing-CADD
Computational Chemistry
Targeted Drug Delivery (Smart Drug Delivery)
New Trends in Pharmacology & Drug Development
Cancer Studies: Drug Delivery and Chemistry
Drugs for Emerging Diseases
Neurodegenerative Diseases
Chem-Virology (Zika Virus)
Chemical Biology
ChemBioChem-Antimicrobials and Infectious Agents & Diseases
Organic and Medicinal Chemistry
Carbon Chemistry
Hyphenated Chromatographic Techniques
 

Why to attend???

Meet your target market with members from around the world focused on learning about advertising and marketing, this is your single best opportunity to reach the largest assemblage of participants from all over the world. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in advertising and marketing fields are hallmarks of this conference.
 

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://medicinalchemistry.pharmaceuticalconferences.com/sponsors.php
 

Major Marketing Associations around the Globe

·         American Association for Clinical Chemistry

·         American Chemical Society

·         American Institute of Chemists (AIC)

·         American Society of Brewing Chemists

·         American Society for Mass Spectrometry

·         Royal Society of Chemistry (RSC)

·         Swedish Chemical Society

·         New Swiss Chemical Society

·         Syngenta, Hyderabad Area, India

·         DCTG, Beijing City, China

·         Oceanus Group Ltd, Singapore
 

Major Marketing Associations in USA

·         American Association for Clinical Chemistry

·         American Chemical Society

·         American Institute of Chemists(AIC)

·         American Society of Brewing Chemists

·         American Society for Mass Spectrometry
 

Statistical Analysis of Associations

 

 

Associations & Societies

Figure 1: Statistical Analysis
 

Target Audience:

Directors/Managers & Business Intelligence Experts, Departmental Managers, Vice Presidents/Directors & Brand Manufacturers/ Marketers of Consumer Products. Retailers, Marketing, Advertising and Promotion Agency Executives, Solution Providers (Digital and Mobile Technology, P-O-P Design, Retail Design, and Retail Execution), Professors and Students from academia in the study of marketing and advertising filed.
 

Top Universities in Texas:

Texas Tech University Health Sciences Center
The University of Texas at Austin
Texas A&M University
University of Houston
University of Texas at San Antonio
Texas State University
 

 

Universities

Figure2: Top Universities in Dallas & Texas

USA Pharmaceutical Companies Associated with Advertising and Marketing Activities

The United States is the largest market for pharmaceuticals (including biopharmaceuticals), accounting for around 35 percent of the global market, and is the world leader in biopharmaceutical research and development (R&D). According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct the majority of the world's research and development in pharmaceuticals and hold the intellectual property rights on most new medicines. The biopharmaceutical pipeline also has over 7,000 new medicines currently in development around the world with approximately 3,500 compounds currently being studied in the United States - more than any other region around the world. The National Science Foundation reports that the U.S. biopharmaceutical sector accounts for the largest single share of all U.S. business research and development (R&D) investment, representing 23.4 percent of all domestic R&D funded by U.S. business in 2013.


More than 854,000 people work in the biopharmaceutical industry in the United States across a broad range of occupations, such as scientific research, technical support and manufacturing. Directly and indirectly, the industry supports a total of 4.4 million jobs across the United States and added an estimated $1.2 trillion in economic output in 2014, representing 3.8 percent of total U.S. output. The biopharmaceutical industry provides average salaries well above the average for all U.S. workers, and requires a highly-skilled and educated workforce from the administrative level up to and including Ph.D. scientists.  

Fast growing segments of the pharmaceutical market include biologics, generics and over-the-counter (OTC) drugs. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval. U.S. generic drug sales reached an estimated $70 billion in 2015, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favouring generics.  OTC market growth will be driven by a growing aging population, consumer trends towards self-medication, and the conversion of drugs from prescription to non-prescription or OTC status.

The United States has one of the world’s most supportive domestic environments for the development and commercialization of pharmaceuticals with minimal market barriers. Its strengths include an intellectual property system that rewards innovation through patent and data protection, a science-based regulatory system that is considered the most rigorous in the world, the world’s largest scientific research base fostered by academic institutions and decades of government research funding, and robust capital markets. The United States attracts the majority of global venture capital investments in start-up biopharmaceutical enterprises.

In addition, the United States is the world’s largest free-pricing market for pharmaceuticals and has high per capita incomes, a large elderly population, and high rates of chronic diseases and drug consumption. All of these factors ensure that the United States will remain the world’s most important pharmaceutical market for the foreseeable future with healthy growth expected across all product sectors.

USA Pharmaceutical Organizations

Figure 3:  Companies Associated with Advertising and Marketing
 

 

Glance at Market of Advertising and Marketing:

It has estimated that in the field of medicinal chemistry more than $79 million in research funding has spent since 2008. A complete overview of drug designing process has come up with some crucial details that from year 2008 to 2013 the market has a growth with $ 198 Billion and in further this rate may increases to $236 Billion from year 2014 to 2019. Special emphasis is given on computational approaches for drug discovery along with salient features and applications of the software’s used in denovo drug designing.

In the future year of 2020, the revenue budget of drug designing or drug production reveals that the large drug companies are facing the expiry of patents on their best sellers. At the same time they are having trouble inventing new medicines, and this means that the drug industry’s sales may at best tread water and could face some steep drops. The point of market analysis is to see what happens after the immediate patent expirations, like the loss of Lipitor from highly reputed companies, to see what happens next. 

Past Conference Report

MedChem and CADD 2016

Medicinal Chemistry 2016 Report

Conference Series Ltd successfully organized 5th International Conference on Medicinal Chemistry & Computer Aided Drug Designing and Drug Delivery during December 05-07, 2016 at Phoenix, USA and received great and fruitful response. Eminent Scientists, Researchers, Pharmacists, Industry Professionals and scholar students has made their resplendent presence and addressed the gathering.

The theme of the conference “Exploring Chemistry: Electronic Structure Methods, Computational Chemical Analysis & Chromatographic Techniques for Drug Discovery.”

MedChem & CADD-2016 Organizing Committee would like to thank the Moderator of the conference, Ms. Olayide A. Arodola, University of KwaZulu-Natal, South Africa who contributed a lot for the smooth functioning of this event.

Conference Series Ltd would like to convey a great appreciation to following honourable guests and Keynote speakers.

L. Mario Amzel, Johns Hopkins University, USA

Thorsten Nowak, C4X Discovery Holdings PLC., UK

Tatsuya Takagi, Osaka University, Japan

Victor Hruby, University of Arizona, USA

Concepción González-Bello, University of Santiago de Compostela, Spain

Carsten Detering, BioSolveIT Inc., USA

Jetze J. Tepe, Michigan State University

Marc Le Borgne, University Lyon 1, France

Mitsuji Yamashita, Shizuoka University, Japan

Conference Series Ltd also took the privilege of felicitating MedChem & CADD-2016 Organizing Committee, Editorial Board Members of Journal of Medicinal Chemistry,  Journal of Drug Designing and  Biochemistry & Pharmacology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date December 06-08, 2017

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Medicinal Chemistry Journal of Drug Designing Journal of Biomarkers in Drug Development Journal of Pharmaceutical Sciences & Emerging Drugs

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by